SCHEMBL4895594

SCHEMBL4895594

CCN(c1ccc(OCc2cc(C)cc(C)c2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
ALDH1A1 P00352 2/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MMP13 P45452 3/20 0.47
ADAM17 P78536 3/20 0.47
MMP9 P14780 2/20 0.47
KMT2A Q03164 1/20 0.47
TSHR P16473 1/20 0.46
ESR1 P03372 2/20 0.45
KDM4E B2RXH2 1/20 0.44
MCL1 Q07820 1/20 0.43
MMP1 P03956 1/20 0.43
PARP10 Q53GL7 1/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TP53 P04637 1/20 0.42
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895352 0.92 KMT2A (0.54) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4905993 0.91 LMNA (0.56) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4904214 0.90 MMP13 (0.46) LMNAALDH1A1MMP13ADAM17MMP9
SCHEMBL4904188 0.90 LMNA (0.53) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4907030 0.88 LMNA (0.51) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4897482 0.88 LMNA (0.53) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4903420 0.86 LMNA (0.57) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4905308 0.85 MMP2 (0.49) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4905129 0.82 MMP13 (0.52) LMNAALDH1A1MMP13ADAM17MMP9
SCHEMBL4902970 0.82 KEAP1 (0.48) LMNAALDH1A1MMP13ADAM17MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.